This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Vanda Pharmaceuticals Inc.. Active years: 2025.
Company Filing History:
Years Active: 2025
Title: Alexander Keenan: Innovator in Multiple Sclerosis Treatment
Introduction
Alexander Keenan is a notable inventor based in Raritan, NJ (US). He has made significant contributions to the field of medicine, particularly in the treatment of multiple sclerosis. His innovative work focuses on improving the quality of life for patients suffering from this debilitating condition.
Latest Patents
Keenan holds a patent for Ponesimod, a groundbreaking treatment aimed at avoiding the worsening of fatigue-related symptoms in multiple sclerosis patients. The patent outlines methods for treating multiple sclerosis using Ponesimod, specifically targeting patients who have not previously undergone disease-modifying treatment (DMT). The methods described are particularly relevant for individuals with a baseline expanded disability status scale (EDSS) score of ≤3.5 or those without Gd+/T1 lesions at baseline.
Career Highlights
Throughout his career, Alexander Keenan has been associated with Vanda Pharmaceuticals Inc., where he has played a crucial role in advancing therapeutic options for multiple sclerosis. His dedication to research and development has positioned him as a key figure in the pharmaceutical industry.
Collaborations
Keenan has collaborated with esteemed colleagues such as Brian Patrick Hennessy and Tarek El Akkad. These partnerships have fostered an environment of innovation and have contributed to the successful development of new treatment methodologies.
Conclusion
Alexander Keenan's work in the field of multiple sclerosis treatment exemplifies the impact of innovative thinking in medicine. His patent for Ponesimod represents a significant advancement in the management of fatigue-related symptoms, showcasing his commitment to improving patient outcomes.